India’s Cipla beats quarterly profit, banks on new drug launches for growth
By Rishika Sadam and Kashish Tandon (Reuters) -Cipla, India’s third-largest drugmaker by sales, posted fourth-quarter profit above estimates on Tuesday and said it will focus on new drug launches in the key domestic and U.S. markets to drive growth in the coming years. In India, its largest market by sales, Cipla plans to launch innovative …
India’s Cipla beats quarterly profit, banks on new drug launches for growth Read More »










